Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ruka Hishinuma"'
Autor:
Fumio Sekiya, Ruka Hishinuma, Kaoru Sugimoto, Takayuki Kon, Go Murayama, Katsura Hohtatsu, Makio Kusaoi, Michiaki Kageyama, Michihiro Ogasawara, Ken Yamaji, Takuya Nemoto, Toshio Kawamoto, Risa Yamada, Kazuo Kempe, Hiroshi Tsuda, Misa Yasui, Yoshinari Takasaki
Publikováno v:
Journal of Clinical Apheresis. 29:90-96
We evaluated the bradykinin generation level during leukocytapheresis (LCAP) using novel CellsorbaTM CS-180S, which has sodium pyrosulfite and sodium carbonate as a filling solution. Subjects of this study were 14 rheumatoid arthritis patients. Regar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::accf0bb086011bbdec991049d3629711
https://doi.org/10.1002/jca.21297
https://doi.org/10.1002/jca.21297
Autor:
Risa Yamada, Michiaki Kageyama, Hiroshi Tsuda, Misa Yasui, Ken Yamaji, Yoshinari Takasaki, Makio Kusaoi, Go Murayama, Toshio Kawamoto, Michihiro Ogasawara, Kaoru Sugimoto, Takayuki Kon, Katsura Hohtatsu, Fumio Sekiya, Takuya Nemoto, Kazuo Kempe, Ruka Hishinuma
Publikováno v:
Therapeutic Apheresis and Dialysis. 16:456-466
Leukocytapheresis (LCAP) is a safe, unique therapy pertaining to intractable rheumatoid arthritis (RA) even in cases of drug allergy or infectious states. To investigate how to represent LCAP efficacy, we have conducted gene expression analyses from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e50dd0b28b9e3c9397cc07997cec8ba
https://doi.org/10.1111/j.1744-9987.2012.01111.x
https://doi.org/10.1111/j.1744-9987.2012.01111.x
Publikováno v:
International Journal of Diabetes in Developing Countries. 35:384-385
Dear Sir, Voglibose, an α-glucosidase inhibitor, lowers the daily glycemic excursions and inhibits overwork of the pancreatic β-cells [1]. Recently, voglibose has been reported to reduce the development of type 2 diabetes in individuals with impair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::003559bdc6315974fc0fd1e132031d9f
https://doi.org/10.1007/s13410-014-0242-7
https://doi.org/10.1007/s13410-014-0242-7
Autor:
Makio, Kusaoi, Ken, Yamaji, Go, Murayama, Misa, Yasui, Risa, Yamada, Ruka, Hishinuma, Takuya, Nemoto, Katsura, Hohtatsu, Michiaki, Kageyama, Toshio, Kawamoto, Kaoru, Sugimoto, Fumio, Sekiya, Takayuki, Kon, Michihiro, Ogasawara, Kazuo, Kempe, Hiroshi, Tsuda, Yoshinari, Takasaki
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 16(5)
Leukocytapheresis (LCAP) is a safe, unique therapy pertaining to intractable rheumatoid arthritis (RA) even in cases of drug allergy or infectious states. To investigate how to represent LCAP efficacy, we have conducted gene expression analyses from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8c85130c7306e10fc9513fda39f14efe
https://pubmed.ncbi.nlm.nih.gov/23046371
https://pubmed.ncbi.nlm.nih.gov/23046371
Autor:
Risa, Yamada, Makio, Kusaoi, Go, Murayama, Misa, Yasui, Ruka, Hishinuma, Takuya, Nemoto, Katsura, Hohtatsu, Michiaki, Kageyama, Toshio, Kawamoto, Kaoru, Sugimoto, Fumio, Sekiya, Takayuki, Kon, Michihiro, Ogasawara, Kazuo, Kempe, Ken, Yamaji, Hiroshi, Tsuda, Yoshinari, Takasaki
Publikováno v:
Journal of clinical apheresis. 29(2)
We evaluated the bradykinin generation level during leukocytapheresis (LCAP) using novel Cellsorba(TM) CS-180S, which has sodium pyrosulfite and sodium carbonate as a filling solution. Subjects of this study were 14 rheumatoid arthritis patients. Reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c850922a4c501e0887cea5e48732d4e4
https://pubmed.ncbi.nlm.nih.gov/24023037
https://pubmed.ncbi.nlm.nih.gov/24023037